Comprehensive review of hepatitis in canines: Etiology, pathogenesis, diagnosis, treatment and management

Introduction

Hepatitis in dogs refers to inflammation of the liver, a condition that represents a broad clinical syndrome rather than a single disease entity. This inflammation may occur abruptly as acute hepatitis or may progress gradually over months, resulting in chronic hepatitis. Although hepatitis in humans has been extensively researched, canine hepatitis remains less clearly understood due to limited studies and the frequent absence of an identifiable cause in many canine cases. Because the underlying triggers are often unknown, veterinary diagnosis and treatment usually rely on the microscopic appearance of liver tissue, especially patterns of degeneration, inflammation, fibrosis, and necrosis. For this reason, consistent and standardized interpretation of liver histopathology is crucial. Standardized reporting helps avoid misinterpretation, reduces contradictory diagnoses, and supports effective communication among veterinary professionals. It also improves collaboration across research centres working to better define and classify liver disorders in dogs. The WSAVA Liver Diseases and Pathology Standardization Research Group is currently leading efforts to unify the classification of canine liver diseases. Their work includes the refinement of terminology related to parenchymal liver disorders and the development of internationally accepted diagnostic criteria. Establishing uniform definitions for the various forms of canine hepatitis is a key foundation for advancing research, identifying new causes, and developing improved treatments.

Acute Hepatitis

A rapid onset of liver inflammation characterizes acute hepatitis.

Microscopically, it typically includes: inflammatory cell infiltration, Hepatocellular necrosis or programmed cell death, and Early attempts at tissue regeneration. The severity and distribution of liver cell injury vary depending on the cause, the dog's immune response and the duration of the condition. Identifying the type and extent of inflammation and necrosis is essential for diagnosis and guiding treatment. A particularly severe form, known as fulminant hepatitis, involves extensive and sudden destruction of liver tissue, resulting in acute liver failure. In such cases, dogs may deteriorate rapidly-sometimes fatally-within as little as 48 hours after clinical signs appear.

Chronic Hepatitis

Chronic hepatitis develops when liver inflammation persists over an extended period. It is typically marked by: Ongoing hepatocyte apoptosis or necrosis, Mononuclear or mixed inflammatory infiltrates, Attempts at regeneration, varying degrees of fibrosis. The activity of the disease reflects the level of inflammation and ongoing cell death, while the stage refers to the degree of fibrosis and architectural disruption of the liver. Severe fibrosis may progress to cirrhosis, where normal liver architecture is replaced by nodules and scar tissue, leading to irreversible liver dysfunction. The pattern of fibrosis-whether patchy, bridging or diffuse-affects both prognosis and treatment planning.

Infectious Canine Hepatitis (ICH)

Infectious Canine Hepatitis (ICH) is a viral disease that primarily targets the liver and is caused by Canine Adenovirus Type 1 (CAV-1). Although it shares the name "hepatitis," it is unrelated to the hepatitis viruses that infect humans; therefore, infected dogs pose no risk to people or to human health. CAV-1 can infect domestic dogs as well as certain wild canids such as wolves, foxes and coyotes, and occasionally other species like bears. Once a dog becomes infected, the virus replicates in the tonsils and lymphoid tissues before spreading to the liver, kidneys, and the lining of blood vessels. The incubation period generally ranges from 4 to 9 days. While many dogs are protected through routine vaccination, outbreaks can still occur, especially among puppies, unvaccinated dogs, or animals imported from regions with inadequate vaccination protocols. The replacement of early CAV-1 vaccines with the safer CAV-2-based vaccine, which offers cross-protection, has greatly reduced vaccine-related reactions and lowered the prevalence of ICH worldwide. However, severe disease can still emerge in unvaccinated populations. ICH can progress from mild to life-threatening. Some dogs recover fully from the acute infection, while others may develop chronic active hepatitis, potentially leading to cirrhosis as the liver becomes heavily scarred. Clinical Presentation Dogs affected by ICH may show a variety of signs depending on disease severity, including: Fever and lethargy Vomiting and diarrhoea, Abdominal discomfort, Inappetence, Widespread haemorrhages, Respiratory difficulty (less common).

A classic but not universal sign is "blue eye," a temporary corneal opacity that occurs due to immune-complex deposition, typically 1-3 weeks after recovery from the acute illness.

Transmission

The virus is shed in Urine, Feces, Saliva, and Nasal secretions. Transmission occurs through direct contact or exposure to contaminated environments. Notably, infected dogs can continue shedding the virus in their urine for months after clinical recovery. signs of ICH. The Labrador succumbed to seizures and hemorrhagic gastroenteric signs, while the Beagle exhibited neurological symptoms and urinary incontinence but eventually recovered. Samples (including urine, swabs, and post-mortem tissues) confirmed CAV-1 infection. The incidence of CHV in domestic and colony-bred dogs has been found in serologic studies. In England, 45.8% of dogs tested positive for antibodies, whereas 39.3% of dogs in the Netherlands tested positive. Serologic research in Italy has found that the frequency is higher in kennelled dogs (27.9%), whereas it is lower in pets (3.1%). Host Range and Global Distribution While domestic dogs are the primary hosts, CAV-1 infects a variety of wild carnivores, including Red foxes, Wolves, Coyotes, Bears Mustelids (e.g., weasels, martens, otters). Seroprevalence varies widely by region. Studies have shown up to 97% prevalence in isolated redfox populations. Antibodies in several North American carnivores, including polar bears and sea lions A fatal case in a Eurasian river otter. High environmental resistance of the virus enables prolonged persistence in contaminated areas, contributing to ongoing risks in wildlife and unvaccinated domestic dogs.

Pathogenesis

The development of Infectious Canine Hepatitis follows a predictable sequence beginning with viral entry and culminating in widespread organ damage. Understanding this progression helps explain the wide variety of clinical signs and the rapid deterioration that can occur in severe cases.

Entry and Initial Replication The CAV-1 virus typically

enters the body when a dog inhales or ingests contaminated secretions such as urine, feces, saliva, or nasal discharge. After entry, the virus first multiplies in the tonsils. It then spreads to nearby lymphoid tissues.

From there, it enters the bloodstream, producing viremia. This early replication phase allows the virus to disseminate quickly throughout the body. 4. Avoiding Exposure to Wild Carnivores Because CAV-1 circulates among wild canids-including foxes, wolves, and coyotes-contact between domestic dogs and wildlife should be minimized. This is particularly important in rural, suburban, or wooded areas where wildlife activity is common.

Canine Hepatitis Caused by Intrahepatic Bacteria

Canine hepatitis may also arise from bacterial infiltration of liver tissue, either as a primary infection or secondary to biliary, gastrointestinal, or systemic disease. When bacteria invade the hepatic parenchyma, they trigger varying degrees of inflammation, which can resemble other forms of hepatitis but require different diagnostic and therapeutic approaches. Veterinary pathologists classify these bacterialassociated liver diseases under categories such as: Acute hepatitis, Chronic hepatitis, Granulomatous hepatitis (GH), Pyogranulomatous inflammation, Cholangiohepatitis, Lobular dissecting hepatitis. These conditions are recognized in the histologic classification system established by the World Small Animal Veterinary Association (WSAVA).

Etiology

A wide range of bacteria have been implicated in canine hepatic inflammation. They may originate from the intestine, biliary system, bloodstream, or adjacent organs. Common Enteric Bacteria. These are frequently found in dogs with bacterial hepatitis: Escherichia coli, Enterococcus spp. Bacteroides spp. Streptococcus spp. Clostridium spp. Helicobacter canis Non-enteric Bacteria. Less common but clinically significant pathogens include: Leptospira spp. Bartonella spp. Clostridium piliforme (Tyzzer's disease) Mycobacterium spp. These organisms may reach the liver through hematogenous spread, biliary reflux, or systemic infection.

Clinical Findings

Dogs with bacterial hepatitis often show non-specific systemic signs that overlap with other liver diseases. Typical clinical features include: Lethargy and weakness, reduced appetite or complete anorexia, Vomiting, Abdominal discomfort or palpable abdominal tension Fever (pyrexia). Common laboratory abnormalities include neutrophilia, thrombocytopenia, Hypoalbuminemia, Hyperglobulinemia, and Elevated alkaline phosphatase (ALP), often greater than ALT elevations. These patterns may suggest cholestasis or a mixed inflammatory disease, rather than pure hepatocellular necrosis.

Granulomatous or pyogranulomatous inflammation may coexist with biliary involvement, and identifying specific bacterial organisms can be challenging. Some dogs show bacterial morphology consistent with Helicobacter or Leptospira, though confirmatory testing may not always support infection.

Diagnosis

Accurate diagnosis requires combining clinical data, imaging, cytology, culture, and molecular techniques. Diagnostic considerations include: Ultrasound changes may overestimate liver echogenicity due to surrounding mesenteric inflammation or abdominal fluid. Bile cultures are often more frequently positive than liver tissue cultures, especially in cases of cholangitis or bile duct obstruction. Bacteria frequently isolated include E. coli and Enterococcus spp., correlating with organisms identified histologically. The presence of bacteria in both liver and spleen suggests bacteraemia and hematogenous spread.

Additional diagnostic tools

Fluorescence in situ hybridization (FISH) can pinpoint bacteria within inflammatory lesions. 16S rRNA sequencing: identifies bacterial species when culture is inconclusive.

Histopathology: demonstrates the relationship between bacteria and inflammatory infiltrates. A major limitation is that not all cases undergo advanced testing due to sample availability or financial constraints.

Treatment

Bacterial hepatitis can be life-threatening; empirical antimicrobial therapy is initiated while awaiting culture results.

Broad-spectrum coverage may include: Fluoroquinolones, Doxycycline or other tetracyclines, Chloramphenicol, Amoxicillin-Agents targeting atypical bacteria such as Bartonella or Mycobacterium when clinically indicated. Therapy may continue for 4-8 weeks, depending on response, severity, and culture findings.

Additional considerations:

Dogs may show ultrasonographic features suggestive of pancreatitis, but confirmatory testing may be negative. Concurrent diseases (e.g., bile duct obstruction) must also be treated to prevent recurrence. Overall, treatment success depends on identifying the bacterial source, relieving biliary obstruction if present, and providing adequate antimicrobial courses.

Canine Hepatitis Caused by Toxins and Chemicals

Certain toxins, chemicals, and metabolic abnormalities can trigger liver inflammation in dogs. These non-infectious forms of hepatitis vary widely depending on the type of toxin, the dog's genetic predisposition, and the duration or intensity of exposure. Some breeds are more susceptible to toxin-associated hepatitis due to inherited deficiencies in copper metabolism or other metabolic pathways.

1. Breed Predispositions Several dog breeds display a higher-than-average incidence of chronic hepatitis, likely due to underlying genetic factors: Cocker Spaniels (American and English), West Highland White Terriers, Skye Terriers, Dalmatians, Labrador Retrievers, Doberman Pinschers, Bedlington Terriers. Conversely, some breeds, such as Beagles, rarely develop chronic hepatitis. Copper-Associated Hepatitis. In certain breeds, abnormal copper metabolism contributes significantly to chronic liver disease: Bedlington Terriers. Copper toxicosis is linked to a deletion in exon 2 of the MURR1 gene. West Highland White Terriers, Dalmatians, Skye Terriers, and Labradors may also develop copper accumulation due to genetic predispositions. Excess copper in hepatocytes leads to oxidative damage, cell death, and chronic inflammation. Alpha-1 Antitrypsin-Associated Hepatitis In English Cocker Spaniels, elevated levels of intracellular alpha-1 antitrypsin contribute to chronic hepatitis. Similar to affected humans, defective secretion of this protein results in its accumulation within the hepatocyte endoplasmic reticulum, eventually causing cell injury and chronic inflammation.

Toxic Liver Injury:

The liver is particularly vulnerable to toxins because it: Receives blood directly from the gastrointestinal tract, is responsible for metabolizing drugs, chemicals, and xenobiotics, and converts certain substances into more reactive or harmful metabolites. Dogs and cats are especially sensitive to toxic injury due to relatively low levels of protective antioxidants such as glutathione. Common Categories of Hepatotoxins Drugs (e.g., acetaminophen, chemotherapy agents) Environmental chemicals Plants and fungi (e.g., aflatoxins, certain mushrooms) Idiosyncratic reactions where liver injury occurs unpredictably in a small number of exposed animals Mechanisms of Toxicity Toxins can injure the liver through Secondary effects may include: Inflammation, Cholestasis, Fibrosis. A major challenge is that many toxins produce overlapping histological patterns, making it difficult to determine the exact cause based solely on tissue appearance. Acute injuries dominated by necrosis may lack significant inflammation early on, while chronic injuries typically involve fibrosis, persistent inflammation, and architectural distortion.

Infectious Disease Interaction Some infectious agents produce hepatic necrosis that closely mimics toxic injury. Examples include:

Canine and feline herpesviruses, Clostridium piliforme (Tyzzer's disease), Toxoplasma, Neospora, Sarcocystis, and FIP virus in cats. These conditions often result in widespread necrosis with minimal inflammation early, making differentiation from toxic hepatitis challenging.

References

1. Bromberg PA, Robin ED, Forkner CE. The existence of ammonia in blood in vivo with observations on the NH₄⁺-NH₃ system. J Clin Invest. 1960;39(2):332-341.
2. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987;67(2):440-519.
3. Solanki K, Desai A, Dalvi M, Jani H. Review on important diseases of dogs: At glance. Int J Vet Sci Anim Husbandry. 2023;8(2):01-07.
4. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathydefinition, nomenclature, diagnosis, and quantification. Hepatology. 2002;35(3):716-721.
5. Shawcross DL, Damink SO, Butterworth RF, Jalan R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab Brain Dis. 2005;20:169-179.
6. Weber FL, Veach GL. Gastrointestinal production of ammonia. Gastroenterology. 1979;77(5):1166. International Journal of Advanced Biochemistry Research https://www.biochemjournal.com
7. Dunn BE, Campbell GP, Perez-Perez GI, Blaser MJ. Purification and characterization of urease from Helicobacter pylori. J Biol Chem. 1990;265(16):94649469.